News summary

Plasma proteomics identifies four candidate biomarkers associated with macrovascular complications in type 2 diabetes: evidence from a clinical cohort and an animal model

Source: Frontiers - Health • Published: 30 Oct 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

Proteomics identified four plasma biomarkers associated with macrovascular disease.

Plasma proteomics identifies four candidate biomarkers associated with macrovascular complications in type 2 diabetes: evidence from a clinical cohort and an animal model
Key Takeaways
  • A four‑protein panel discriminated macrovascular disease in T2DM.
  • ADSL and MGAT1 were independently associated with macrovascular disease.
  • LGALS3 and VSIG4 were upregulated and correlated with inflammation.
Read the full article at Frontiers - Health ↗

Continue exploring

Recommended MoL Picks

MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickPlan Your Health Tests in Three MinutesThe free Personal Health Diagnostics Planner turns a short questionnaire into a ranked, personalised PDF: a clearer starting point for deciding which health checks deserve attention now.